Endo Flashcards
Criteria for growth failure
Height below 1st percentile,
Or height >2SD below mid-parental height
GH level consistent with GH deficiency
<10 ng/mL in each of 2 provocative tests
GH deficiency is almost universal 5 yr after therapy with a total dose of
> = 35 Gy
End organ resistance to GH due to mutation of the GH receptor
Laron syndrome
Concurrent treatment with GH and __ has been used to interrupt puberty and delay epiphyseal fusion and prolong growth
GnRH agonist
Criteria for stopping treatment of GH
- Decision by the patient that he or she is tall enough
- growth rate <1 in/yr
- bone age >14 yr in girls, >16 in boys
The diagnosis of DI is established by serum osmolality __ and urine osmolality __. Unlikely if serum osmolality is __ and urine osmolality is __.
Serum osm >300 mOsm/kg Urine osm <300 mOsm/kg Unlikely if Serum osm <270 Urine osm >600
DI, DM, optic atrophy, deafness
Wolfram syndrome
Triphasic response following neurosurgery
- Transient DI (12-48 hr)
- SIADH (up to 10 days)
- Permanent DI
__ is the cause of 50% of cases of “idiopathic” central DI
Hypophysitis
Urine sodium excretion in CSW
> 150 meq/L
ANP >20pmol/L
Gold standard for diagnosis of GH excess
Failure to suppress GH to <5 ng/dL after 1.75 g/kg oral glucose challenge
Competes with GH for binding to the GH receptor
Pegvisomant
Bromocriptine
Classification
Indication
Dopamine agonist
GH and prolactin oversecretion
Octreotide
Classification
Indication
Somatostarin analog
GH excess